Hoth Therapeutics Announces Pipeline Presentation at the 2022 Sidoti Investor Conference


NEW YORK, Aug. 12, 2022 /PRNewswire/ --Hoth Therapeutics Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, today announced today announced the company will be presenting at the Sidoti Investor Conference taking place on August 17-18, 2022.

To learn more about the Sidoti Investor Conference or register to attend visit

About Hoth Therapeutics, Inc.
Hoth Therapeutics is a clinical-stage biopharmaceutical company dedicated to develop innovative, impactful, and ground-breaking treatments with a goal to improve patient quality of life. We are a catalyst in early-stage pharmaceutical research and development, elevating drugs from the bench to pre-clinical and clinical testing. Utilizing a patient-centric approach, we collaborate and partner with a team of scientists, clinicians, and key opinion leaders to seek out and investigate therapeutics that hold immense potential to create  breakthroughs  and  diversify  treatment  options.  To  learn  more,  please visit

Investor Contact:
LR Advisors LLC
Phone: (678) 570-6791


Cision View original content to download multimedia:

SOURCE Hoth Therapeutics, Inc.

Company Codes: NASDAQ-NMS:HOTH

Back to news